Interestingly, the same study also reported that significantly higher expression of LFA-1 and VLA-4 was detected on CLL cells derived from high-risk patients with unfavorable cytogenetic abnormalities such as trisomy 12, deletion 17p or deletion 11q (226). This evidence concerns the gene ITGAL and B-cell chronic lymphocytic leukemia.